The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

MMRF-Led Immunotherapy Approaches Make a Splash at ASH

The third day of the 58th Annual ASH Meeting offered numerous exciting presentations about several up-and-coming approaches to treating myeloma with immunotherapy. A morning session focused enhancing the effectiveness of stem cell transplant, an important treatment option for eligible patients. Afternoon presentations focused on treatment with antibodies that help the immune system recognize myeloma cells and other new types of therapy. READ MORE

Posted: December 06, 2016

4 Promising Myeloma Treatments Bring Hope to Patients

Day 2 of the 58th Annual ASH Meeting included exciting results from several studies of new therapies being examined in clinical trials; the MMRC, the clinical network of the MMRF, has played a critical role in accelerating a number of these agents forward. The overarching takeaway from all of the data was that myeloma is complex but highly treatable. Excitingly, several of the new treatments are for patients who have specific genomic features. READ MORE

Posted: December 05, 2016

Record-Breaking CoMMpass Results Presented at World's Premier Hematology Event

The world’s largest society of hematology professionals—American Society of Hematology (ASH)—kicked off its annual meeting today in San Diego. More than 20,000 clinicians, scientists, key players in pharmaceutical industries, government agencies, and nonprofit research foundations were present for the 58th ASH Annual Meeting - the indisputable premier meeting for the presentation of the latest multiple myeloma data. READ MORE

Posted: December 04, 2016

Page 11 of 87« First...910111213...203040...Last »